Genetically modified rodent models of SCA17

Journal of Neuroscience Research

Volumn 95, Issue 8, 2017, Pages 1540-1547

  Cui, Yiting ^a,b   Yang, Su ^b   Li, Xiao Jiang ^b   Li, Shihua ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HDL4; Huntington disease like 4; SCA17; spinocerebellar ataxia type 17

Indexed keywords

POLYGLUTAMINE; TATA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL DOMINANT INHERITANCE; CAG REPEAT; CEREBELLAR ATAXIA; CONTROLLED STUDY; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; RODENT MODEL; SPINOCEREBELLAR ATAXIA TYPE 17; TRANSGENIC MOUSE; TRANSGENIC RAT; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; RODENT; SPINOCEREBELLAR DEGENERATION; TRANSGENIC ANIMAL; TRINUCLEOTIDE REPEAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; PHENOTYPE; RODENTIA; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN; TRINUCLEOTIDE REPEATS;

EID: 85002704981     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23984     Document Type: Review

References (31)

1. Bauer P, Laccone F, Rolfs A, Wullner U, Bosch S, Peters H, Liebscher S, Scheible M, Epplen JT, Weber BH, et al. 2004. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet 41:230–232.
2. Brooks SP, Dunnett SB. 2009. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 10:519–529.
3. Bruni AC, Takahashi-Fujigasaki J, Maltecca F, Foncin JF, Servadio A, Casari G, D'Adamo P, Maletta R, Curcio SA, De Michele G, et al. 2004. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 61:1314–1320.
4. Chang YC, Lin CY, Hsu CM, Lin HC, Chen YH, Lee-Chen GJ, Su MT, Ro LS, Chen CM, Hsieh-Li HM. 2011. Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17. J Neurochem 118:288–303.
5. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, et al. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101–106.
6. Friedman MJ, Shah AG, Fang ZH, Ward EG, Warren ST, Li S, Li XJ. 2007. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci 10:1519–1528.
7. Friedman MJ, Wang CE, Li XJ, Li S. 2008. Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. J Biol Chem 283:8283–8290.
8. Fujigasaki H, Martin JJ, De Deyn PP, Camuzat A, Deffond D, Stevanin G, Dermaut B, Van Broeckhoven C, Durr A, Brice A. 2001. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124(Pt 10):1939–1947.
9. Gao R, Matsuura T, Coolbaugh M, Zuhlke C, Nakamura K, Rasmussen A, Siciliano MJ, Ashizawa T, Lin X. 2008. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet 16:215–222.
10. Gostout B, Liu Q, Sommer SS. 1993. “Cryptic” repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am J Hum Genet 52:1182–1190.
11. Huang S, Ling JJ, Yang S, Li XJ, Li S. 2011. Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain 134(Pt 7):1943–1958.
12. Huang S, Yang S, Guo J, Yan S, Gaertig MA, Li S, Li XJ. 2015. Large polyglutamine repeats cause muscle degeneration in SCA17 mice. Cell Rep 13:196–208.
13. Kelp A, Koeppen AH, Petrasch-Parwez E, Calaminus C, Bauer C, Portal E, Yu-Taeger L, Pichler B, Bauer P, Riess O, et al. 2013. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. J Neurosci 33:9068–9081.
14. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. 1999. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 8:2047–2053.
15. Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, Wolters A, Kock N, Steinlechner S, Nagel M, Zuhlke C, et al. 2006. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 129(Pt 9):2341–2352.
16. Maltecca F, Filla A, Castaldo I, Coppola G, Fragassi NA, Carella M, Bruni A, Cocozza S, Casari G, Servadio A, et al. 2003. Intergenerational instability and marked anticipation in SCA-17. Neurology 61:1441–1443.
17. Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. 2007. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 104:18259–18264.
18. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I. 2001. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10:1441–1448.
19. Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP. 2010. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67:936–952.
20. Roeder RG. 1991. The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly. Trends Biochem Sci 16:402–408.
21. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schols L, Riess O. 2003. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 54:367–375.
22. Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K, Takahashi R, Kitazawa S, Hattori N. 2010. A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189:180–185.
23. Silveira I, Miranda C, Guimaraes L, Moreira MC, Alonso I, Mendonca P, Ferro A, Pinto-Basto J, Coelho J, Ferreirinha F, et al. 2002. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 59:623–629.
24. Stevanin G, Brice A. 2008. Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4). Cerebellum 7:170–178.
25. Toyoshima Y, Yamada M, Onodera O, Shimohata M, Inenaga C, Fujita N, Morita M, Tsuji S, Takahashi H. 2004. SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 55:281–286.
26. van Roon-Mom WM, Reid SJ, Faull RL, Snell RG. 2005. TATA-binding protein in neurodegenerative disease. Neuroscience 133:863–872.
27. Walton JC, Schilling K, Nelson RJ, Oberdick J. 2012. Sex-dependent behavioral functions of the Purkinje cell-specific Galphai/o binding protein, Pcp2(L7). Cerebellum 11:982–1001.
28. Whaley NR, Fujioka S, Wszolek ZK. 2011. Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis 6:33.
29. Yang S, Huang S, Gaertig MA, Li XJ, Li S. 2014. Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice. Neuron 81:349–365.
30. Yang S, Li XJ, Li S. 2016. Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis, Rare Diseases, 4:1, e1223580.
31. Zuhlke C, Hellenbroich Y, Dalski A, Kononowa N, Hagenah J, Vieregge P, Riess O, Klein C, Schwinger E. 2001. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 9:160–164.